Logo image of SOND

SONDER HOLDINGS INC (SOND) Stock Fundamental Analysis

NASDAQ:SOND - Nasdaq - US83542D3008 - Common Stock - Currency: USD

2.72  -0.05 (-1.81%)

After market: 2.78 +0.06 (+2.21%)

Fundamental Rating

1

Taking everything into account, SOND scores 1 out of 10 in our fundamental rating. SOND was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. SOND may be in some trouble as it scores bad on both profitability and health. SOND is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SOND has reported negative net income.
SOND had a negative operating cash flow in the past year.
In the past 5 years SOND always reported negative net income.
In the past 5 years SOND always reported negative operating cash flow.
SOND Yearly Net Income VS EBIT VS OCF VS FCFSOND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M -200M -250M

1.2 Ratios

SOND has a Return On Assets of -24.36%. This is amonst the worse of the industry: SOND underperforms 95.49% of its industry peers.
Industry RankSector Rank
ROA -24.36%
ROE N/A
ROIC N/A
ROA(3y)-76.07%
ROA(5y)-93.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SOND Yearly ROA, ROE, ROICSOND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

The Gross Margin of SOND (38.29%) is worse than 65.41% of its industry peers.
SOND's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SOND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.04%
GM growth 5YN/A
SOND Yearly Profit, Operating, Gross MarginsSOND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

SOND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOND has more shares outstanding
The debt/assets ratio for SOND is higher compared to a year ago.
SOND Yearly Shares OutstandingSOND Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
SOND Yearly Total Debt VS Total AssetsSOND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

SOND has an Altman-Z score of -2.07. This is a bad value and indicates that SOND is not financially healthy and even has some risk of bankruptcy.
SOND has a Altman-Z score of -2.07. This is amonst the worse of the industry: SOND underperforms 92.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.07
ROIC/WACCN/A
WACC3.44%
SOND Yearly LT Debt VS Equity VS FCFSOND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

2.3 Liquidity

A Current Ratio of 0.22 indicates that SOND may have some problems paying its short term obligations.
SOND has a worse Current ratio (0.22) than 96.24% of its industry peers.
SOND has a Quick Ratio of 0.22. This is a bad value and indicates that SOND is not financially healthy enough and could expect problems in meeting its short term obligations.
SOND's Quick ratio of 0.22 is on the low side compared to the rest of the industry. SOND is outperformed by 93.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
SOND Yearly Current Assets VS Current LiabilitesSOND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

SOND shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.38%.
Looking at the last year, SOND shows a quite strong growth in Revenue. The Revenue has grown by 8.61% in the last year.
Measured over the past years, SOND shows a very strong growth in Revenue. The Revenue has been growing by 73.29% on average per year.
EPS 1Y (TTM)-6.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.49%
Revenue 1Y (TTM)8.61%
Revenue growth 3Y73.29%
Revenue growth 5YN/A
Sales Q2Q%0.76%

3.2 Future

The Earnings Per Share is expected to decrease by -120.66% on average over the next years. This is quite bad
The Revenue is expected to grow by 16.66% on average over the next years. This is quite good.
EPS Next Y-693.1%
EPS Next 2Y-120.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.55%
Revenue Next 2Y21.03%
Revenue Next 3Y19.35%
Revenue Next 5Y16.66%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SOND Yearly Revenue VS EstimatesSOND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SOND Yearly EPS VS EstimatesSOND Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SOND. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SOND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SOND Price Earnings VS Forward Price EarningsSOND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOND Per share dataSOND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

A cheap valuation may be justified as SOND's earnings are expected to decrease with -120.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-120.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONDER HOLDINGS INC

NASDAQ:SOND (7/3/2025, 8:10:07 PM)

After market: 2.78 +0.06 (+2.21%)

2.72

-0.05 (-1.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-04 2025-08-04
Inst Owners40.67%
Inst Owner Change1.84%
Ins Owners8.89%
Ins Owner Change44.27%
Market Cap31.52M
Analysts43.33
Price TargetN/A
Short Float %11.09%
Short Ratio7.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.02%
Min Revenue beat(2)-19.88%
Max Revenue beat(2)-18.15%
Revenue beat(4)0
Avg Revenue beat(4)-15.13%
Min Revenue beat(4)-19.88%
Max Revenue beat(4)-5.97%
Revenue beat(8)2
Avg Revenue beat(8)-8.12%
Revenue beat(12)5
Avg Revenue beat(12)-2.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.26
EYN/A
EPS(NY)-6.83
Fwd EYN/A
FCF(TTM)-11.11
FCFYN/A
OCF(TTM)-10.99
OCFYN/A
SpS53.77
BVpS-46.33
TBVpS-46.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.29%
FCFM N/A
ROA(3y)-76.07%
ROA(5y)-93.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.04%
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.72%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -2.07
F-Score2
WACC3.44%
ROIC/WACCN/A
Cap/Depr(3y)85.74%
Cap/Depr(5y)106.16%
Cap/Sales(3y)4.94%
Cap/Sales(5y)8.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.49%
EPS Next Y-693.1%
EPS Next 2Y-120.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.61%
Revenue growth 3Y73.29%
Revenue growth 5YN/A
Sales Q2Q%0.76%
Revenue Next Year24.55%
Revenue Next 2Y21.03%
Revenue Next 3Y19.35%
Revenue Next 5Y16.66%
EBIT growth 1Y32.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.52%
EBIT Next 3Y34.44%
EBIT Next 5Y24.08%
FCF growth 1Y35.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.01%
OCF growth 3YN/A
OCF growth 5YN/A